Atlas Trials

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis

Clinical trial NCT07548853 · RECRUITING

Trial details

NCT number
NCT07548853
Sponsor
Taisho Pharmaceutical Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperphosphatemia Patients on Peritoneal Dialysis
Start date
2026-05-13
Primary completion
2027-05-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.